Table 4.
Treatment-related adverse events in the an-WBRT group.
| an-WBRT(n = 34) | |||||
|---|---|---|---|---|---|
| Grade, No. (%) | |||||
| Adverse event* | 1 | 2 | 3 | 4 | 5 |
| Asthenia | 3 (8.8) | 3 (8.8) | 2 (5.9) | 0 | 0 |
| Anorexia | 3 (8.8) | 1 (2.9) | 2 (5.9) | 0 | 0 |
| Hypertension | 1 (2.9) | 4 (11.8) | 1 (2.9) | 0 | 0 |
| Diarrhea | 0 | 0 | 1 (2.9) | 0 | 0 |
| Hemoptysis | 0 | 0 | 0 | 0 | 1 (2.9) |
| Leukoencephalopathy | 0 | 0 | 1 (2.9) | 0 | 0 |
*Grade 1–2 adverse events that affected more than 10% of patients in an-WBRT group and all grade 3–5 adverse events are included. Only toxicity of higher grade would be counted in a patient with the same acute and late adverse event but at different levels.